The function of miR-637 in non-small cell lung cancer progression and prognosis.

Teng JiaXiaojie Gu


Non-small cell lung cancer (NSCLC) is the most common type of lung cancer with a high mortality rate and poor prognosis. miR-637 has been reported to regulate tumor progression and act as a prognosis biomarker of various cancers. Its functional role in NSCLC was investigated in this study. The expression level of miR-637 in NSCLC tissues and adjacent normal tissues of 123 NSCLC patients was analyzed by qRT-PCR. The association between miR-637 and clinical pathological features in the prognosis of patients was analyzed. Cell transfection was performed to overexpress or knockdown miR-637 in H1299 and HCC827. The proliferation, migration, and invasion of H1299 and HCC827 were evaluated by CCK8 and Transwell assay. miR-637 expression was significantly decreased in NSCLC tissues and cell lines relative to normal tissues and cells. The survival rate of NSCLC patients with low miR-637 expression was lower than that of patients with high miR-637 expression. Additionally, miR-637 served as a tumor suppressor that inhibited cell proliferation, migration, and invasion of NSCLC. Downregulation of miR-637 in NSCLC was associated with TNM stage and poor prognosis of patients and served as a tumor suppressor in NSCLC. These results provide a ...Continue Reading


Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jin-fang ZhangHsiang-fu Kung
Feb 22, 2012·EMBO Molecular Medicine·Marilena V Iorio, Carlo M Croce
May 24, 2013·Chemical Reviews·Haifeng DongXueji Zhang
Jan 31, 2015·Seminars in Liver Disease·Ashley M Mohr, Justin L Mott
Feb 27, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Ling SunFengming Luo
Oct 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·You-Jin LuYing Wang
Oct 25, 2017·Cancer Biomarkers : Section a of Disease Markers·Suoning LiuWei Li
Nov 22, 2017·PET Clinics·Tim Akhurst
Jan 2, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Mitsuhiro IsakaYasuhisa Ohde
Feb 15, 2018·Journal of Endocrinological Investigation·P ZhaoY Wang
Aug 16, 2018·Nature Reviews. Molecular Cell Biology·Luca F R Gebert, Ian J MacRae
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Wan-Tao WangRong-Bao Yan
Apr 25, 2019·International Journal of Molecular Sciences·Mohamed SalemChun Peng
Aug 6, 2019·Mayo Clinic Proceedings·Narjust DumaJulian R Molina
Nov 28, 2019·Cancer Biomarkers : Section a of Disease Markers·Wenqi LiuLi Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.